Corvus Pharmaceuticals Inc

NASDAQ:CRVS   3:59:53 PM EDT
4.60
+0.04 (+0.88%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Corvus Pharmaceuticals Inc Stock, NASDAQ:CRVS

863 Mitten Road, Suite 102, Burlingame, California 94010
United States of America
Phone: +1.650.900.4520
Number of Employees: 42

Description

Corvus Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of oncology therapies. The firm focuses on disabling cancerâ??s ability to subvert immune attack by inhibiting adenosine in the tumor microenvironment and by blocking its production by tumors. Its product pipeline includes B Cell Activator, Adenosine Production Inhibitor Anti-CD73, ITK Inhibitor, A2AR Inhibitor, Anti-CXCR2, and A2BR Inhibitor. The company was founded by Richard A. Miller, Peter A. Thompson and Joseph J. Buggy on January 27, 2014 and is headquartered in Burlingame, CA.